Automation index

How much of a Dosimetrist’s job can AI already do?

A dose plan comes earlier. The tumour getting it and the healthy organ not, for real, do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

22%

AI can already do 22% of this job.

#336 / 643

Dosimetrist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
CT, contours and the plan. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Organ at risk, the curve and not overshooting. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Physics, the check and the one that does not fit. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Fraction, the setup and the patient who is not the same. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
The oncologist, the trade-off and not signing blind. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
The tumour gets it, and the healthy organ does not. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		22%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

27%

#171 / 643

Nuclear medicine physician

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
PET, SPECT protocols and a stock report. Estimate No public source provides a precise figure. This is our estimate.	18%	52%	+9.4
Order dose, timing and preparation. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Give the isotope and watch the reaction. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Clinic, the cancer that returns and the family. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Quality, waste and radiation protection. Estimate No public source provides a precise figure. This is our estimate.	16%	32%	+5.1
Signing the study and the dose you cannot repeat. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low